Publications
Phase 2 pilot trial to optimise pharmacometric evaluations in Chagas disease (CHARM: CHAgas disease PharMacometrics)
Cruz, C., Watson, J., Molina Romero, I., & White, N. (2024).
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: an individual patient data meta-analysis of two proof of concept trials
Watson, J., Cruz, C., Barreira, F., Forsyth, C., Schijman, A., Peploe, R., Assmus, F., Naylor, C., Lee, J., Mehra, S., Tarning, J., Torrico, F., Gascon, J., Ortiz, L., Ribeiro, I., Sosa-Estani, S., Tipple, C., Hugonnet, S., Guérin, P., … White, N. (2024). In medRxiv.
The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform.
Maguire, B., Dahal, P., Rashan, S., Ngu, R., Boon, A., Forsyth, C., Strub-Wourgaft, N., Chatelain, E., Barreira, F., Sosa-Estani, S., & Guérin, P. (2021). PLoS Neglected Tropical Diseases, 15(8), e0009697.
THE CHAGAS DISEASE STUDY LANDSCAPE: PRELIMINARY ANALYSIS OF A SYSTEMATIC REVIEW OF CLINICAL TRIALS AND OBSERVATIONAL STUDIES TO ASSESS THE FEASIBILITY OF ESTABLISHING AN INDIVIDUAL PARTICIPANT-LEVEL DATA (IPD) PLATFORM
Maguire, B., Chatelain, E., Barreira, F., Estani, S., & Guerin, P. (2018). AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 99(4), 180-180.